Bayer to sell testosterone drug for up to 500 mn euros

German chemicals giant Bayer said on Thursday it was selling its male testosterone replacement drug Nebido for up to half-a-billion euros in order to concentrate on medical innovation.

Bayer and fellow German chemicals firm Gruenenthal had “entered into a definitive agreement regarding the sale of…